Study demonstrates long-term safety and clinical benefit of combination therapy for cystic fibrosis

Patients with cystic fibrosis (CF) face difficulty breathing and a decline in lung function and are at risk of early death. CF is an inherited condition that results in thick mucus build-up, persistent infection and inflammation in the lungs.

Related Keywords

South Carolina ,United States ,University Of South Carolina ,Emily Henderson ,Carolina Clinical Translational Research ,Nexus Research Center ,Adult Cystic Fibrosis Center ,Patrick Flume ,Cystic Fibrosis ,Cystic Fibrosis Center ,South Carolina Clinical ,Translational Research ,Industry Focus ,Ibrosis ,Breathing ,Fell ,Drugs ,Education ,Health Care ,Hospital ,Inflammation ,Lungs ,Medicine ,Utation ,Pharmaceuticals ,Protein ,Research ,Students ,